Sumitomo Pharma Co., Ltd. (DNPUF)
9.27
+0.86
(+10.29%)
USD |
OTCM |
Aug 25, 16:00
Sumitomo Pharma Profit Margin (Quarterly) : 13.13% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.13% |
| March 31, 2026 | -0.77% |
| December 31, 2025 | 7.31% |
| September 30, 2025 | 73.58% |
| June 30, 2025 | 10.38% |
| March 31, 2025 | 2.29% |
| December 31, 2024 | 47.54% |
| September 30, 2024 | -53.47% |
| June 30, 2024 | 17.57% |
| March 31, 2024 | -248.0% |
| December 31, 2023 | -60.64% |
| September 30, 2023 | -37.52% |
| June 30, 2023 | -51.35% |
| March 31, 2023 | -67.26% |
| December 31, 2022 | -12.33% |
| September 30, 2022 | -27.18% |
| June 30, 2022 | 17.57% |
| March 31, 2022 | 4.23% |
| December 31, 2021 | 3.76% |
| September 30, 2021 | 17.95% |
| June 30, 2021 | 0.62% |
| March 31, 2021 | -17.39% |
| December 31, 2020 | 20.69% |
| September 30, 2020 | 11.57% |
| June 30, 2020 | 11.63% |
| Date | Value |
|---|---|
| March 31, 2020 | -6.41% |
| December 31, 2019 | 10.80% |
| September 30, 2019 | 20.89% |
| June 30, 2019 | 5.71% |
| March 31, 2019 | 7.70% |
| December 31, 2018 | 10.02% |
| September 30, 2018 | 11.45% |
| June 30, 2018 | 13.15% |
| December 31, 2017 | -1.17% |
| September 30, 2017 | 16.49% |
| June 30, 2017 | 21.20% |
| March 31, 2017 | -0.55% |
| December 31, 2016 | 17.36% |
| September 30, 2016 | 2.70% |
| June 30, 2016 | 8.08% |
| March 31, 2016 | 1.37% |
| December 31, 2015 | 9.59% |
| September 30, 2015 | 7.22% |
| June 30, 2015 | 6.05% |
| March 31, 2015 | -3.84% |
| December 31, 2014 | 7.17% |
| September 30, 2014 | 6.78% |
| June 30, 2014 | 6.41% |
| March 31, 2014 | 0.87% |
| December 31, 2013 | 10.14% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Eisai Co., Ltd. | 8.17% |
| Chugai Pharmaceutical Co., Ltd. | 34.06% |
| Santen Pharmaceutical Co., Ltd. | 10.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 40.88% |
| Return on Assets | 14.59% |
| Return on Invested Capital | 21.92% |
| Gross Profit Margin (Quarterly) | 52.57% |
| Operating Margin (Quarterly) | 13.45% |
| Return on Net Operating Assets | 18.88% |